Balance Sheet
AssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Current Leases (2020 - 2025)

Benitec Biopharma's Current Leases history spans 5 years, with the latest figure at $137000.0 for Q4 2024.

  • For Q4 2024, Current Leases changed N/A year-over-year to $137000.0; the TTM value through Dec 2024 reached $137000.0, changed N/A, while the annual FY2024 figure was $284000.0, 3.27% up from the prior year.
  • Current Leases for Q4 2024 was $137000.0 at Benitec Biopharma, down from $211000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $292000.0 in Q1 2024 and bottomed at $137000.0 in Q4 2024.
  • The 5-year median for Current Leases is $213000.0 (2021), against an average of $227866.7.
  • The largest annual shift saw Current Leases dropped 2.02% in 2021 before it surged 32.99% in 2022.
  • A 5-year view of Current Leases shows it stood at $203000.0 in 2020, then fell by 4.43% to $194000.0 in 2021, then soared by 32.99% to $258000.0 in 2022, then rose by 6.59% to $275000.0 in 2023, then plummeted by 50.18% to $137000.0 in 2024.
  • Per Business Quant, the three most recent readings for BNTC's Current Leases are $137000.0 (Q4 2024), $211000.0 (Q3 2024), and $284000.0 (Q2 2024).